GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

GPCR ligand binding

pathways : GPCR ligand binding pathways:

Fullview (zoomIn)


Related Pathways to "GPCR ligand binding" content :


Related Genes to "GPCR ligand binding" content :

preload


Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products :

Catalog number Product name Quantity
N1I1 VDR-LBD. Purified GST-tagged human Vitamin D receptor ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1H4 FXR-LBD. Purified GST-tagged human Farnesoid X receptor ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N2B1 RXRA-LBD. Purified GST-tagged human Retinoid X receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1H3 LXRA-LBD. Purified GST-tagged human Liver X receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N2B3 RXRG-LBD. Purified GST-tagged human Retinoid X receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1H2 LXRB-LBD. Purified GST-tagged human Liver X receptor beta ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N2B2 RXRB-LBD. Purified GST-tagged human Retinoid X receptor beta ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N3B1 ESRRA-LBD. Purified GST-tagged human Estrogen-related receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1F1 RORA-LBD. Purified GST-tagged human RAR-related orphan receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N3B3 ESRRG-LBD. Purified GST-tagged human Estrogen-related receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1F3 RORG-LBD. Purified GST-tagged human RAR-related orphan receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1B3 RARG-LBD. Purified GST-tagged human Retinoic acid receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1B2 RARB-LBD. Purified GST-tagged human Retinoic acid receptor beta ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N3B2 ESRRB-LBD. Purified GST-tagged human Estrogen-related receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1B1 RARA-LBD. Purified GST-tagged human Retinoic acid receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1A2 THRB-LBD. Purified GST-tagged human Thyroid hormone receptor beta ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1C3 PPARG-LBD. Purified GST-tagged human Peroxisome proliferator-activated receptor gamma ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
N1C1 PPARA-LBD. Purified GST-tagged human Peroxisome proliferator-activated receptor alpha ligand binding domain. Applications: Ligand-binding and coregulator displacement assays. 50 ug
GPCR75-101AP PC-GPCR (WB control) Orphan GPCR Immunogen: peptide Host: Rabbit 100-150ul
P-GPCR Orphan GPCR, Antigen blocking peptide 100ul
EIAAB39229 Gp250,LDLR relative with 11 ligand-binding repeats,Low-density lipoprotein receptor relative with 11 ligand-binding repeats,LR11,Mouse,mSorLA,Mus musculus,Sorl1,SorLA-1,Sortilin-related receptor,Sorti
GPCR75-101AP GPCR-Biotin (Biotin Conjugates) Orphan GPCR Immunogen: peptide Host: Rabbit 200ul
GPCR75-101AP GPCR-FITC (FITC-conjugates) Orphan GPCR Immunogen: peptide Host: Rabbit 200ul
GPCR75-101AP P-GPCR (Antigenic peptide) Orphan GPCR Immunogen: peptide Host: Rabbit 100ul
PC-GPCR Orphan GPCR, WB control 100-150ul

Pathways :

WP1825: GPCR ligand binding
WP1089: Small Ligand GPCRs
WP1317: Small Ligand GPCRs
WP1398: GPCR-orphan-noGO
WP1531: Vitamin D synthesis
WP161: Small Ligand GPCRs
WP1616: ABC transporters
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP1824: GPCR downstream signaling
WP1869: Neuroransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
WP1899: Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs)
WP1912: Signaling by GPCR
WP2059: Alzheimers Disease
WP2075: Alzheimers Disease
WP2292: Chemokine signaling pathway
WP2355: Corticotropin-releasing hormone
WP247: Small Ligand GPCRs
WP353: Small Ligand GPCRs
WP590: Cardiovascular Signaling
WP731: Sterol regulatory element binding protein related
WP746: Small Ligand GPCRs
WP853: Small Ligand GPCRs
WP971: Small Ligand GPCRs

Related Genes :
[Htr1a Gpcr18] 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A)
[Ffar2 Gpr43 Lssig] Free fatty acid receptor 2 (G-protein coupled receptor 43) (Leukocyte-specific STAT-induced GPCR)
[F2rl1 Gpcr11 Gpr11 Par2] Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1)
[Aplnr Agtrl1 Apj] Apelin receptor (Angiotensin receptor-like 1) (B78) (G-protein coupled receptor APJ) (GPCR34)
[GPER1 CEPR CMKRL2 DRY12 GPER GPR30] G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER)
[GTG1 At1g64990 F13O11.29] GPCR-type G protein 1
[GTG2 At4g27630 T29A15.120] GPCR-type G protein 2
[FFAR2 FFA2 GPCR43 GPR43] Free fatty acid receptor 2 (G-protein coupled receptor 43)
[Htr1d Gpcr14] 5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin receptor 1D)
[Cxcr2 Cmkar2 Gpcr16 Il8rb] C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (CD antigen CD182)
[Ednra Gpcr10] Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ET-AR)
[FASLG APT1LG1 CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Faslg Apt1lg1 Cd95l Fasl gld Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Faslg Apt1Lg1 Cd95l Fasl Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Lpar1 Edg2 Gpcr26 Lpa1 Vzg1] Lysophosphatidic acid receptor 1 (LPA receptor 1) (LPA-1) (Lysophosphatidic acid receptor Edg-2) (Rec1.3) (VZG-1)
[Cmklr1 Dez Gpcr27] Chemokine-like receptor 1 (G-protein coupled receptor DEZ)
[Drd1 Drd1a Gpcr15] D(1A) dopamine receptor (Dopamine D1 receptor)
[Lpar1 Edg2 Gpcr91 Lpa1] Lysophosphatidic acid receptor 1 (LPA receptor 1) (LPA-1) (Lysophosphatidic acid receptor Edg-2)
[GPR62] G-protein coupled receptor 62 (G-protein coupled receptor GPCR8) (hGPCR8) (G-protein coupled receptor KPG_005)
[GPRC5A GPCR5A RAI3 RAIG1] Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1)
[GPR61 BALGR GPCR3] G-protein coupled receptor 61 (Biogenic amine receptor-like G-protein coupled receptor)
[Lnx1 Lnx] E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb protein X 1) (Ligand of Numb-binding protein 1) (Numb-binding protein 1) (RING-type E3 ubiquitin transferase LNX)
[COLD1 Os04g0600800 LOC_Os04g51180 OsJ_16035 OSJNBa0083N12.15] GPCR-type G protein COLD1 (Protein CHILLING TOLERANCE DIVERGENCE 1)
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[GPRC6A] G-protein coupled receptor family C group 6 member A (hGPRC6A) (G-protein coupled receptor GPCR33) (hGPCR33)

Bibliography :
[31103421] Conformational Complexity and Dynamics in a Muscarinic Receptor Revealed by NMR Spectroscopy.
[31096719] Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
[31096158] Allostery in G protein-coupled receptors investigated by molecular dynamics simulations.
[31094506] Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening towards a G Protein-Coupled Receptor.
[31092552] Context-dependent signalling of CXC chemokine receptor 4 (CXCR4) and atypical chemokine receptor 3 (ACKR3).
[31082696] Current status of multiscale simulations on GPCRs.
[31077988] Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool.
[31067065] Targeted delivery of a ligand-drug conjugate via formyl peptide receptor 1 through cholesterol-dependent endocytosis.
[31023886] Stepwise activation of a class C GPCR begins with millisecond dimer rearrangement.
[31022570] Characterising GPCR-ligand interactions using a fragment molecular orbital-based approach.